Literature DB >> 25681555

Non-alcoholic fatty liver - perhaps not so benign.

Leon A Adams1, Vlad Ratziu2.   

Abstract

Keywords:  Biopsy; NAFLD; Natural history

Mesh：

Year:  2015        PMID： 25681555     DOI： 10.1016/j.jhep.2015.02.005

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  16 in total

Review 1.  The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View.

Authors:  Christina C Lindenmeyer; Arthur J McCullough
Journal:  Clin Liver Dis       Date:  2018-02       Impact factor: 6.126

Review 2.  Pathogenesis of nonalcoholic steatohepatitis.

Authors:  Wensheng Liu; Robert D Baker; Tavleen Bhatia; Lixin Zhu; Susan S Baker
Journal:  Cell Mol Life Sci       Date:  2016-02-19       Impact factor: 9.261

3.  Effect of telmisartan and vitamin E on liver histopathology with non-alcoholic steatohepatitis: A randomized, open-label, noninferiority trial.

Authors:  Shahinul Alam; Mushfiqul Abrar; Saiful Islam; Mohammad Kamal; Mohammad J Hasan; Md Abdullah S Khan; Nooruddin Ahmad
Journal:  JGH Open       Date:  2020-03-02

Review 4.  Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Gregory Thomas Brown; David E Kleiner
Journal:  Metabolism       Date:  2015-12-02       Impact factor: 8.694

Review 5.  Natural History of Nonalcoholic Fatty Liver Disease.

Authors:  George Boon-Bee Goh; Arthur J McCullough
Journal:  Dig Dis Sci       Date:  2016-03-22       Impact factor: 3.199

6.  Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease.

Authors:  Lihua Jin; Rui Wang; Yanlin Zhu; Weili Zheng; Yaping Han; Fusheng Guo; Frank Bin Ye; Yong Li
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

Review 7.  Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence.

Authors:  Guillermo Mazzolini; Jan-Peter Sowa; Catalina Atorrasagasti; Özlem Kücükoglu; Wing-Kin Syn; Ali Canbay
Journal:  Cells       Date:  2020-11-11       Impact factor: 6.600

Review 8.  The Natural Course of Non-Alcoholic Fatty Liver Disease.

Authors:  Luis Calzadilla Bertot; Leon Anton Adams
Journal:  Int J Mol Sci       Date:  2016-05-20       Impact factor: 5.923

9.  Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients.

Authors:  Franck Chiappini; Audrey Coilly; Hanane Kadar; Philippe Gual; Albert Tran; Christophe Desterke; Didier Samuel; Jean-Charles Duclos-Vallée; David Touboul; Justine Bertrand-Michel; Alain Brunelle; Catherine Guettier; François Le Naour
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

Review 10.  Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease.

Authors:  Anne Fougerat; Alexandra Montagner; Nicolas Loiseau; Hervé Guillou; Walter Wahli
Journal:  Cells       Date:  2020-07-08       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.